REPL · ISSUER CIK 1737953
Replimune Group, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Replimune Group, Inc. insiders reported $0.00 of open-market purchases and $1.0M of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$1.0MInsider selling
−$1.0MNet open-market
Aug 24, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 202619:48 | Aug 20, 2026 | REPL | Director | G · Gift | — | −50,000 | 1,362,414 | -4% | — | ||
| Aug 19, 202618:42 | Aug 17, 2026 | REPL | Chief Financial Officer | S · Sell | $14.28 | −9,256 | 215,852 | -4% | −$132K | ||
| Aug 12, 202617:07 | Aug 10, 2026 | REPL | Chief Executive Officer, Director | S · Sell | $12.97 | −39,341 | 708,151 | -5% | −$510K | ||
| Aug 12, 202617:06 | Aug 10, 2026 | REPL | Chief Financial Officer | S · Sell | $12.97 | −11,448 | 225,108 | -5% | −$148K | ||
| Aug 12, 202617:05 | Aug 10, 2026 | REPL | Chief Medical Officer | S · Sell | $12.97 | −11,447 | 224,215 | -5% | −$148K | ||
| Aug 12, 202617:04 | Aug 10, 2026 | REPL | Chief Accounting Officer | S · Sell | $12.97 | −7,632 | 99,425 | -7% | −$99K |